SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-217088
Filing Date
2018-07-13
Accepted
2018-07-12 20:07:12
Documents
6
Period of Report
2018-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d367931d6k.htm 6-K 12515
2 EX-99.1 d367931dex991.htm EX-99.1 9380
3 EX-99.2 d367931dex992.htm EX-99.2 47031
4 EX-99.3 d367931dex993.htm EX-99.3 14486
5 GRAPHIC g367931g14x03.jpg GRAPHIC 4270
6 GRAPHIC g367931g90n43.gif GRAPHIC 3023
  Complete submission text file 0001193125-18-217088.txt   94703
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38079 | Film No.: 18951463
SIC: 2834 Pharmaceutical Preparations